References
- American Cancer Society. Cancer Facts & Figures 2012. www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-031941.pdf
- Kallunki T , OlsenOD, JäätteläM. Cancer-associated lysosomal changes: friends or foes?Oncogene32, 1995–2004 (2013).
- Boya P , KroemerG. Lysosomal membrane permeabilization in cell death. Oncogene27, 6434–6451 (2008).
- Kirkegaard T , JäätteläM. Lysosomal involvement in cell death and cancer. Biochim. Biophys. Acta.1793, 746–754 (2009).
- Kreuzaler P , WatsonCJ. Killing a cancer: what are the alternatives?Nat. Rev. Cancer.12, 411–424 (2012).
- Appelqvist H , WasterP, KagedalK, OllingerK. The lysosome: from waste bag to potential therapeutic target. J. Mol. Cell Biol.5, 214–226 (2013).
- Groth-Pedersen L , JäätteläM. Combating apoptosis and multidrug resistant cancers by targeting lysosomes. Cancer Lett.332, 265–274 (2013).
- Chung M-F , ChenK-J, LiangH-Fet al. A liposomal system capable of generating CO2 bubbles to induce transient cavitation, lysosomal rupturing, and cell necrosis. Angew. Chemie Int. Edit.51, 10089–10093 (2012).
- Latorre M , RinaldiC. Applications of magnetic nanoparticles in medicine: magnetic fluid hyperthermia. PR Health Sci. J.28, 227–238 (2009).
- Kozissnik B , BohorquezAC, DobsonJ, RinaldiC. Magnetic fluid hyperthermia: advances, challenges, and opportunity. Int. J. Hyperther.29, 706–714 (2013).
- Creixell M , BohórquezAC, Torres-lugoM, RinaldiC. EGFR-targeted magnetic nanoparticle heaters kill cancer cells without a sensible temperature rise. ACS Nano5, 7124–7129, (2011).
- Rodríguez-Luccioni HL , Latorre-EstevesM, Méndez-VegaJet al. Enhanced reduction in cell viability by hyperthermia induced by magnetic nanoparticles. Int. J. Nanomed.6, 373–380 (2011).
- Alvarez-Berríos MP , CastilloA, MendézJ, SotoO, RinaldiC, Torres-LugoM. Hyperthermic potentiation of cisplatin by magnetic nanoparticle heaters is correlated with an increase in cell membrane fluidity. Int. J. Nanomed.11, 1003–1013 (2013).
- Alvarez-Berrios MP , CastilloA, RinaldiC, Torres-LugoM. Magnetic fluid hyperthermia enhances cytotoxicity of bortezomib in sensitive and resistant cancer cell lines. Int. J. Nanomed.9, 145–153 (2014).
- Torres-Lugo M , RinaldiC. Thermal potentiation of chemotherapy by magnetic nanoparticles. Nanomedicine8, 1689–1707 (2013).
- Silva AC , OliveiraTR, MamaniJBet al. Application of hyperthermia induced by superparamagnetic iron oxide nanoparticles in glioma treatment. Int. J. Nanomedicine6 591–603 (2011).
- Maier-Hauff K , UlrichF, NestlerD. Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiformeJ. Neurooncol.103317–3242011
- Polo-Corrales L , RinaldiC. Monitoring iron oxide nanoparticle surface temperature in an alternating magnetic field using thermoresponsive fluorescent polymers. J. Appl. Phys.111, 07B334 (2012).
- Riedinger A , GuardiaP, CurcioA. Subnanometer local temperature probing and remotely controlled drug release based on azo-functionalized iron oxide nanoparticlesNano Lett132399–24062013
- Sanchez C , El Hajj DiabD, ConnordV. Targeting a G-protein-coupled receptor overexpressed in endocrine tumors by magnetic nanoparticles to induce cell deathACS Nano81350–13632014
- Domenech M , Marrero-BerriosI, Torres-LugoM, RinaldiC. Lysosomal membrane permeabilization by targeted magnetic nanoparticles in alternating magnetic fields. ACS Nano.7, 5091–5101 (2013).